<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Exp Med</journal-id><journal-id journal-id-type="iso-abbrev">J. Exp. Med</journal-id><journal-title-group><journal-title>The Journal of Experimental Medicine</journal-title></journal-title-group><issn pub-type="ppub">0022-1007</issn><issn pub-type="epub">1540-9538</issn><publisher><publisher-name>The Rockefeller University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">9874572</article-id><article-id pub-id-type="pmc">PMC1887694</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Mature Follicular Dendritic Cell Networks Depend on Expression of Lymphotoxin &#x003b2; Receptor by Radioresistant Stromal Cells and of Lymphotoxin &#x003b2; and Tumor Necrosis Factor by B Cells </article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Endres</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="N0x35686a0N0x214e7d8">*</xref></contrib><contrib contrib-type="author"><name><surname>Alimzhanov</surname><given-names>Marat B.</given-names></name><xref ref-type="aff" rid="N0x35686a0N0x214e7d8">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Plitz</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="N0x35686a0N0x214e7d8">*</xref></contrib><contrib contrib-type="author"><name><surname>F&#x000fc;tterer</surname><given-names>Agnes</given-names></name><xref ref-type="aff" rid="N0x35686a0N0x214e7d8">*</xref></contrib><contrib contrib-type="author"><name><surname>Kosco-Vilbois</surname><given-names>Marie H.</given-names></name><xref ref-type="aff" rid="N0x35686a0N0x214e7d8">&#x000a7;</xref></contrib><contrib contrib-type="author"><name><surname>Nedospasov</surname><given-names>Sergei A.</given-names></name><xref ref-type="aff" rid="N0x35686a0N0x214e7d8">&#x02016;</xref></contrib><contrib contrib-type="author"><name><surname>Rajewsky</surname><given-names>Klaus</given-names></name><xref ref-type="aff" rid="N0x35686a0N0x214e7d8">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Pfeffer</surname><given-names>Klaus</given-names></name><xref ref-type="aff" rid="N0x35686a0N0x214e7d8">*</xref></contrib></contrib-group><aff id="N0x35686a0N0x214e7d8">From the <label>*</label>Institute of Medical Microbiology, Immunology and Hygiene, Technical University of Munich, D-81675 Munich, Germany; the <label>&#x02021;</label>Institute for Genetics, University of Cologne, D-50931 Cologne, Germany; <label>&#x000a7;</label>Serono Pharmaceutical Research Institute, Plan-les-Ouates, CH-1228, Switzerland; and the <label>&#x02016;</label>Engelhardt Institute of Molecular Biology and Belozersky Institute of Physico-Chemical Biology, 117984 Moscow, Russia</aff><author-notes><fn><p>Address correspondence to Klaus Pfeffer, Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Trogerstr. 9, D-81675 Munich, Germany. Phone: 49-89-4140-4132; Fax: 49-89-4140-4183; E-mail: <email>klaus.pfeffer@lrz.tu-muenchen.de</email>
</p></fn></author-notes><pub-date pub-type="ppub"><day>4</day><month>1</month><year>1999</year></pub-date><volume>189</volume><issue>1</issue><fpage>159</fpage><lpage>168</lpage><history><date date-type="received"><day>8</day><month>9</month><year>1998</year></date><date date-type="rev-recd"><day>13</day><month>10</month><year>1998</year></date></history><permissions><copyright-year>1999</copyright-year><license license-type="openaccess"><license-p>This article is distributed under the terms of an Attribution&#x02013;Noncommercial&#x02013;Share Alike&#x02013;No Mirror Sites license for the first six months after the publication date (see <ext-link ext-link-type="uri" xlink:href="http://www.rupress.org/terms">http://www.rupress.org/terms</ext-link>). After six months it is available under a Creative Commons License (Attribution&#x02013;Noncommercial&#x02013;Share Alike 4.0 Unported license, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/">http://creativecommons.org/licenses/by-nc-sa/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The formation of germinal centers (GCs) represents a crucial step in the humoral immune response. Recent studies using gene-targeted mice have revealed that the cytokines tumor necrosis factor (TNF), lymphotoxin (LT) &#x003b1;, and LT&#x003b2;, as well as their receptors TNF receptor p55 (TNFRp55) and LT&#x003b2;R play essential roles in the development of GCs. To establish in which cell types expression of LT&#x003b2;R, LT&#x003b2;, and TNF is required for GC formation, LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup>, LT&#x003b2;<sup>&#x02212;/&#x02212;</sup>, TNF<sup>&#x02212;/&#x02212;</sup>, B cell&#x02013;deficient (BCR<sup>&#x02212;/&#x02212;</sup>), and wild-type mice were used to generate reciprocal or mixed bone marrow (BM) chimeric mice. GCs, herein defined as peanut agglutinin&#x02013;binding (PNA<sup>+</sup>) clusters of centroblasts/centrocytes in association with follicular dendritic cell (FDC) networks, were not detectable in LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> hosts after transfer of wild-type BM. In contrast, the GC reaction was restored in LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> hosts reconstituted with either wild-type or LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> BM. In BCR<sup>&#x02212;/&#x02212;</sup> recipients reconstituted with compound LT&#x003b2;<sup>&#x02212;/&#x02212;</sup>/BCR<sup>&#x02212;/&#x02212;</sup> or TNF<sup>&#x02212;/&#x02212;</sup>/BCR<sup>&#x02212;/&#x02212;</sup> BM grafts, PNA<sup>+</sup> cell clusters formed in splenic follicles, but associated FDC networks were strongly reduced or absent. Thus, development of splenic FDC networks depends on expression of LT&#x003b2; and TNF by B lymphocytes and LT&#x003b2;R by radioresistant stromal cells.</p></abstract><kwd-group><kwd>lymphotoxin</kwd><kwd>tumor necrosis factor</kwd><kwd>bone marrow transfer</kwd><kwd>follicular dendritic cell</kwd><kwd>germinal center</kwd></kwd-group></article-meta></front><body><p>In the course of a humoral immune response, germinal centers (GCs)<sup>1</sup> represent the microenvironment where antigen-specific B cells efficiently undergo clonal expansion, diversification of their Ig genes, selection for clones bearing B cell receptors (BCRs) of high affinity to the antigen, and differentiation into memory or plasma cells (for reviews, see references <xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B3" ref-type="bibr">3</xref>). To support the GC reaction, B cells, T cells, and follicular dendritic cells (FDCs), the three major cellular constituents of GCs, have to interact in an intricate way. In brief, FDCs trap and retain native antigen complexed with antibody and complement, and also provide contact-dependent antigen-nonspecific costimulatory signals that facilitate chemotaxis and proliferation of B cells (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). It is believed that the trapped antigen can be best endocytosed by B cells with increased affinity of their BCRs to the antigen (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). These B cells then present the processed antigen to CD4<sup>+</sup> T cells, which on their part, together with FDCs, support further proliferation and differentiation of the selected B cells towards preplasma cells or memory B cells (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>).</p><p>Over the past few years, several members of the TNF/ lymphotoxin (LT) receptor and ligand families have been shown to play essential roles in the induction of GCs. Prominent members mediating this function are the TNFRp55, the LT&#x003b2;R, and their ligands TNF, LT&#x003b1;, and LT&#x003b2;. Both LT&#x003b1; and TNF form homotrimers (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>) which signal via TNFRp55 and TNFRp75 (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>). LT&#x003b1;<sub>3</sub> is only secreted by activated lymphocytes and NK cells (<xref rid="B7" ref-type="bibr">7</xref>), whereas TNF<sub>3</sub> exists both in a membrane-bound and soluble form (<xref rid="B10" ref-type="bibr">10</xref>) and can be produced by many different cell types, including macrophages, T, and B cells (<xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>). LT&#x003b1; can also associate with LT&#x003b2;, a membrane-bound type II protein (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>). The LT&#x003b1;<sub>1</sub>&#x003b2;<sub>2</sub> heterotrimer engages the LT&#x003b2;R, which is expressed on macrophages and in lymphoid and visceral tissues, but not on T or B lymphocytes (<xref rid="B16" ref-type="bibr">16</xref>&#x02013;<xref rid="B18" ref-type="bibr">18</xref>). Mice deficient in TNFRp55, LT&#x003b2;R, TNF, or LT&#x003b1; all lack GCs, as defined by the absence of both peanut agglutinin&#x02013;binding (PNA<sup>+</sup>) clusters of centroblasts/centrocytes and associated FDC networks in B cell areas (<xref rid="B19" ref-type="bibr">19</xref>&#x02013;<xref rid="B21" ref-type="bibr">21</xref>). LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> mice differ in their phenotype in that some small PNA<sup>+</sup> clusters are detectable in the B cell areas, but associated FDC networks are absent or strongly reduced (<xref rid="B22" ref-type="bibr">22</xref>&#x02013;<xref rid="B24" ref-type="bibr">24</xref>). Expression of LT&#x003b1; and TNFRp55 by B cells and radioresistant stromal cells, respectively, was shown to be required for GC formation (<xref rid="B25" ref-type="bibr">25</xref>&#x02013;<xref rid="B29" ref-type="bibr">29</xref>). However, no data concerning the cell lineages required to express LT&#x003b2;R, LT&#x003b2;, and TNF for GC development are available.</p><p>This study demonstrates that engagement of the LT&#x003b2;R on radioresistant stromal cells is mandatory for creating an intact splenic microarchitecture, allowing T&#x02013;B cell segregation and establishment of GCs. Moreover, for full development of splenic FDC networks, B lymphocytes are required to produce both LT&#x003b2; and TNF.</p><sec sec-type="materials|methods" id="MaterialsMethods"><title>Materials and Methods</title><sec disp-level="3"><title>Mice.</title><p>LT&#x003b2;- and LT&#x003b2;R-deficient mice were generated as described previously (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>). BCR-deficient mice (<xref rid="B30" ref-type="bibr">30</xref>) and TCR &#x003b2;/&#x003b4;&#x02013;deficient mice (<xref rid="B31" ref-type="bibr">31</xref>) were purchased from The <named-content content-type="company" xlink:href="jackson">Jackson Laboratory</named-content>. Ly5.1<sup>+</sup> C57BL/6 mice were supplied by Dr. H.R. Rodewald (Basel Institute for Immunology, Basel, Switzerland). TNF-deficient mice (<xref rid="B19" ref-type="bibr">19</xref>) were provided by Dr. G. Kollias (Hellenic Pasteur Institute, Athens, Greece). Mice were maintained and bred in a conventional mouse facility in isolated cages according to German guidelines for animal care. 8&#x02013;12-wk-old mice were taken for experiments.</p></sec><sec disp-level="3"><title>Bone Marrow Transfer.</title><p>Bone marrow (BM) cells were harvested by flushing femurs and tibias of donor mice with cold RPMI 1640 medium (Seromed) supplemented with 10% heat-inactivated FCS (Seromed), 2 mM <sc>l</sc>-glutamine (Seromed), 50 &#x003bc;M 2-ME (<named-content content-type="company" xlink:href="gibco">GIBCO BRL</named-content>), 50 &#x003bc;g/ml streptomycin (Seromed), and 100 U/ml penicillin. Cells were washed and depleted of mature T cells using magnetic beads coated with anti-Thy1.2 mAb (<named-content content-type="company" xlink:href="Dynal">Dynal</named-content>) according to the manufacturer's protocol. After the depletion, cells were counted, washed, and resuspended in PBS. Recipient mice were irradiated with 9.5 Gy using a <sup>137</sup>Cs irradiator (Buchler) and injected intravenously with 2 &#x000d7; 10<sup>6</sup> BM cells in 0.2 ml PBS. For mixed BM transfer, 1.5 &#x000d7; 10<sup>6</sup> cells of each genotype were injected in a total volume of 0.2 ml PBS.</p></sec><sec disp-level="3"><title>Immunization.</title><p>6&#x02013;8 wk after the BM transfer, the mice received an intraperitoneal injection of 5 &#x003bc;g of alum-precipitated (4-hydroxy-3-nitrophenyl-acetyl)-chicken gamma globulin (molar ratio 19:1; NP<sub>19</sub>-CG) in 0.2 ml PBS.</p></sec><sec disp-level="3"><title>Evaluation of Chimerism.</title><p>10 d after immunization, mixed BM chimeric mice were killed, and BM, spleens, lymph nodes, and sera were collected. One half of each spleen was frozen for immunohistology, and the other half and all lymph nodes were used to purify B lymphocytes. Single cell suspensions were prepared using nylon cell strainers (<named-content content-type="company" xlink:href="becton">Becton Dickinson</named-content>). Cells were washed and incubated in Tris-buffered ammonium chloride solution to lyse erythrocytes. Cells were then washed in RPMI 1640 medium and in PBS containing 0.5% BSA. At this stage, chimerism of some mice was determined by flow cytometry on a FACScan<sup>&#x000ae;</sup>, using mAbs directed against the Ly5.1 (CD45.1) and Ly5.2 (CD45.2) isoforms conjugated to FITC or PE (<named-content content-type="company" xlink:href="pharmingen">PharMingen</named-content>). B cells were purified by magnetic cell sorting using mouse CD45R (B220) microbeads, MACS<sup>&#x000ae;</sup> VS<sup>+</sup> separation columns and a MACS<sup>&#x000ae;</sup> magnet (Miltenyi Biotec) according to the instructions provided by the manufacturer. The selected fractions were additionally depleted of remaining T cells by magnetic cell sorting using anti-Thy1.2&#x02013;coated Dynabeads (<named-content content-type="company" xlink:href="Dynal">Dynal</named-content>). BM cells were depleted of T cells and of IgM<sup>+</sup>/IgG<sup>+</sup> cells using a cocktail of Dynabeads coated with anti-Thy1.2 or anti-IgM/IgG antibodies (<named-content content-type="company" xlink:href="Dynal">Dynal</named-content>). The purity of cell populations was confirmed by flow cytometry. The percentage of LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> cells in the purified populations was determined by Southern blot hybridization of BamHI-digested genomic DNA using an SphI-PstI fragment of the murine LT&#x003b2; promoter (nucleotides 2977&#x02013;3411, sequence data available from EMBL/GenBank/DDBJ under accession no. <ext-link ext-link-type="gen" xlink:href="U06950">U06950</ext-link>) as a probe. Similarly, the percentage of TNF<sup>&#x02212;/&#x02212;</sup> cells was determined by Southern blot hybridization of EcoRI- digested genomic DNA using a PCR-generated fragment of exon 4 of the TNF gene (PCR primers 5&#x02032;-AGGTCACTGTCCCAGCATCT and 5&#x02032;-GTCAGCCGATTTGCTATCTCA) as a probe. Quantifications of chimerism were performed by densitometry using a PhosphorImager (Molecular Dynamics).</p></sec><sec disp-level="3"><title>Immunohistochemistry.</title><p>Tissue samples were embedded in tissue-freezing medium (Leica) and snap-frozen in 2-methylbutane (Merck) prechilled by liquid nitrogen. Cryostat sections (7 &#x003bc;m) were fixed for 8 min in acetone (Merck), dried, and preincubated for 30 min with PBS containing 5% (vol/vol) goat serum, 1% (wt/vol) BSA, and 0.15% (vol/vol) hydrogen peroxide (<named-content content-type="company" xlink:href="sigma">Sigma</named-content>). Blocking of endogenous biotin was performed using an avidin-biotin blocking kit (Vector) according to the manufacturer's protocol. For double labeling, sections were incubated for 30 min with (a) biotinylated PNA diluted 1:500 (Vector) and rat anti&#x02013; mouse CR1 (CD35) diluted 1:100 (clone 8C12; <named-content content-type="company" xlink:href="pharmingen">PharMingen</named-content>); (b) biotinylated PNA diluted 1:500 (Vector) and rat anti&#x02013;mouse B220 diluted 1:100 (clone RA3-6B2; <named-content content-type="company" xlink:href="pharmingen">PharMingen</named-content>); and (c) biotinylated mouse anti&#x02013;mouse IgD diluted 1:50 (clone 1.3-5), rat anti&#x02013;mouse CD4 diluted 1:100 (GK1.5; <named-content content-type="company" xlink:href="pharmingen">PharMingen</named-content>), and rat anti&#x02013;mouse CD8 used as a 1:2 diluted hybridoma supernatant (clone 53.6-72; American Type Culture Collection). Rat IgG2a and IgG2b (<named-content content-type="company" xlink:href="pharmingen">PharMingen</named-content>) were used as isotype controls. Single labeling was performed with FDC-M1 mAb (clone 4C11). After washing, alkaline phosphatase (AP)-conjugated streptavidin (<named-content content-type="company" xlink:href="sigma">Sigma</named-content>) and/or horseradish peroxidase&#x02013;coupled mouse anti&#x02013;rat IgG (Dianova) were added. After 30 min incubation and washing, color development for bound AP and horseradish peroxidase was consecutively performed with an AP reaction kit (Vector) according to the manufacturer's instructions and with 3-aminoethyl-carbazole (<named-content content-type="company" xlink:href="sigma">Sigma</named-content>) as described (<xref rid="B32" ref-type="bibr">32</xref>). In addition, fluorescent microscopy was used for analysis of sections labeled with PNA and FDC-M2 mAb (clone 209) as described previously (<xref rid="B25" ref-type="bibr">25</xref>).</p></sec><sec disp-level="3"><title>Measurement of Antigen-specific IgG.</title><p>10 d after immunization, NP-specific IgG antibodies were detected using sandwich ELISAs with NP<sub>12</sub>-BSA&#x02013; or NP<sub>5</sub>-BSA&#x02013;conjugated ELISA plates (10 &#x003bc;g/ml in carbonate buffer [pH 9.5]). Murine NP-specific IgG antibodies were detected with an AP-conjugated goat anti&#x02013; mouse IgG antiserum (Dianova). The substrate used was <italic>p</italic>-nitrophenyl phosphate (<named-content content-type="company" xlink:href="sigma">Sigma</named-content>). For calculation of arbitrary binding units of NP-specific IgG antibodies, the standard NP-reactive mAb, N1G9 (<xref rid="B33" ref-type="bibr">33</xref>), was included on each ELISA plate.</p></sec></sec><sec id="Results"><title>Results</title><sec disp-level="4"><title>GC Formation and Intact Splenic Architecture Require Expression of LT&#x003b2;R on Radioresistant Cells.</title><p>To address which cell types have to express LT&#x003b2; or LT&#x003b2;R to initiate and maintain GC reactions, a reciprocal BM transplantation approach was used. BM from C57BL/6 wild-type donors was transferred into myeloablatively irradiated LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> recipients (B6 &#x02192; LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup>) and vice versa (LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> &#x02192; B6). In the same manner, LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> &#x02192; LT&#x003b2;<sup>&#x02212;/&#x02212;</sup>, B6 &#x02192; LT&#x003b2;<sup>&#x02212;/&#x02212;</sup>, and LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> &#x02192; B6 chimeric mice were generated. As a control, BM from C57BL/6 wild-type donors was taken to repopulate irradiated C57BL/6 wild-type recipients (B6 &#x02192; B6). After 8 wk, mice were immunized intraperitoneally with 5 &#x003bc;g NP<sub>19</sub>-CG adsorbed to alum, and 10 d later spleens and sera were taken for analysis. For detection of GCs, a double labeling of spleen sections was performed using the plant lectin PNA and the mAb 8C12. PNA binds to centroblasts/centrocytes, whereas the mAb 8C12 is directed against the murine complement receptor CR1, which is highly expressed on FDCs and at lower levels by B lymphocytes (<xref rid="B34" ref-type="bibr">34</xref>). As shown in Fig. <xref ref-type="fig" rid="F1">1</xref>, E&#x02013;H, in the spleens of B6 &#x02192; LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> animals only a few, small PNA<sup>+</sup> cell aggregates were observed, and FDC networks were completely absent. A similar phenotype was found in immunized LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> mice (<xref rid="B21" ref-type="bibr">21</xref>). An aliquot of the wild-type BM used to reconstitute the LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> recipients was also transferred into LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> recipients. In these mice, the wild-type BM-derived cells were capable of restoring GC formation, proving the intrinsic competence of the donor BM cells (data not shown). Morphologically intact GCs, i.e., PNA<sup>+</sup> cell clusters in association with FDC networks, were also detectable in spleens from LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> &#x02192; LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> (Fig. <xref ref-type="fig" rid="F1">1</xref>, I and J), LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> &#x02192; B6 (data not shown), and B6 &#x02192; B6 (Fig. <xref ref-type="fig" rid="F1">1</xref>, A and B) chimeras. In contrast, wild-type mice reconstituted with LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> BM had fewer and smaller PNA<sup>+</sup> cell clusters with almost undetectable FDC networks (Fig. <xref ref-type="fig" rid="F1">1</xref>, M and N). Presence or absence of FDC networks in association with PNA<sup>+</sup> cell clusters was confirmed by double labeling with PNA and FDC-M2 mAbs or by single labeling with FDC-M1 mAbs (data not shown). </p><p>The anatomical localization of GCs was determined by labeling splenic sections with either PNA and anti-B220 mAbs or anti-IgD, anti-CD4, and anti-CD8 mAbs. Downregulation of IgD on most GC B cells and relatively low numbers of T cells scattered in GCs compared with compact T cell areas in periarteriolar lymphoid sheaths served as criteria for the identification of GCs. In LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> &#x02192; LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> (Fig. <xref ref-type="fig" rid="F1">1</xref>, K and L), LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> &#x02192; B6 (data not shown), and B6 &#x02192; B6 (Fig. <xref ref-type="fig" rid="F1">1</xref>, C and D) chimeric mice, all GCs were correctly localized in the B cell areas. Conversely, in spleens of LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> mice reconstituted with wild-type BM, PNA<sup>+</sup> cell aggregates were found around central arterioles (Fig. <xref ref-type="fig" rid="F1">1</xref>, G and H). T and B cells segregated normally in LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> &#x02192; LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> (Fig. <xref ref-type="fig" rid="F1">1</xref> L), LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> &#x02192; B6 (data not shown), and B6 &#x02192; B6 (Fig. <xref ref-type="fig" rid="F1">1</xref> D) chimeric mice, forming distinct periarteriolar lymphoid sheaths and B cell follicles. In contrast, in B6 &#x02192; LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> mice, T and B cells were mixed despite the presence of hematopoietically derived LT&#x003b2;R<sup>+/+</sup> donor cells (Fig. <xref ref-type="fig" rid="F1">1</xref> H). Taken together, the failure of LT&#x003b2;R<sup>+/+</sup> BM-derived cells to restore GCs and an intact splenic architecture in LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> recipients provides evidence that LT&#x003b2;R on radioresistant stromal cells is required for these functions. However, LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> BM-derived cells were capable of establishing GCs in LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> recipients. This shows that for GC development in adult mice the presence of LT&#x003b2;R on radiosensitive BM-derived cells is dispensable, whereas the presence of LT&#x003b2; on these cells is necessary. The latter conclusion is further supported by the finding that transfer of LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> BM into wild-type C57BL/6 recipients severely impaired GC formation.</p></sec><sec disp-level="4"><title>LT&#x003b2; and TNF from B Cells Are Required for Formation of Mature FDC Networks.</title><p>Expression of LT&#x003b2; and TNF by hematopoietic cell lineages is required for GC formation (results above, and reference <xref rid="B35" ref-type="bibr">35</xref>). Yet it is unclear whether a single hematopoietic lineage is necessary and, perhaps, sufficient for the production of LT&#x003b2; and/or TNF, or whether different cellular sources can redundantly provide these ligands in GC reactions. In particular for TNF, the latter appears to be possible, since a great variety of cell types (e.g., macrophages, granulocytes, T cells, B cells, dendritic cells) can produce both soluble and membrane-bound TNF. Similarly, LT&#x003b2; can be synthesized by three distinct cell types, namely T, B, and NK cells (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B36" ref-type="bibr">36</xref>). Thus, to address the question of which cell type is required to express LT&#x003b2; and TNF for GC establishment, compound BM chimeric mice were made. BM cells from BCR-deficient donors were mixed in a 1:1 ratio with BM cells from TNF<sup>&#x02212;/&#x02212;</sup> or LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> donors and transferred into myeloablatively irradiated BCR<sup>&#x02212;/&#x02212;</sup> recipients (LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup> &#x02192; BCR<sup>&#x02212;/&#x02212;</sup>; TNF<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup> &#x02192; BCR<sup>&#x02212;/&#x02212;</sup>). Control groups were established by reconstituting myeloablatively irradiated BCR<sup>&#x02212;/&#x02212;</sup> recipients with mixed BM from Ly5.1<sup>+</sup> C57BL/6 wild-type donors and LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> or TNF<sup>&#x02212;/&#x02212;</sup> donors (LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> + B6 &#x02192; BCR<sup>&#x02212;/&#x02212;</sup>; TNF<sup>&#x02212;/&#x02212;</sup> + B6 &#x02192; BCR<sup>&#x02212;/&#x02212;</sup>). Since BCR<sup>&#x02212;/&#x02212;</sup> BM cannot give rise to mature B cells, peripheral B cells in the LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup> &#x02192; BCR<sup>&#x02212;/&#x02212;</sup> and TNF<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup> &#x02192; BCR<sup>&#x02212;/&#x02212;</sup> chimeras were genetically deficient in LT&#x003b2; and TNF, respectively. All other radiosensitive BM-derived cell populations consisted of a mixture of wild-type and gene-targeted cells. In control groups (LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> + B6 &#x02192; BCR<sup>&#x02212;/&#x02212;</sup>; TNF<sup>&#x02212;/&#x02212;</sup> + B6 &#x02192; BCR<sup>&#x02212;/&#x02212;</sup>), all BM-derived cell populations&#x02014;including B cells&#x02014;were composed of wild-type and genetically deficient cells. After 6&#x02013;7 wk, mice were immunized intraperitoneally with 5 &#x003bc;g of alum-precipitated NP<sub>19</sub>-CG, and 10 d later BM, spleen, lymph nodes, and serum were taken for analysis. BM chimerism and B cell chimerism were determined by Southern blotting and/or flow cytometric analysis of the CD45 isoforms Ly5.1 and Ly5.2 (see Materials and Methods, and Table <xref ref-type="table" rid="TI">I</xref>). BM chimerism was found to be comparable between experimental and control groups (Table <xref ref-type="table" rid="TI">I</xref>). Immunohistochemical analysis of splenic sections from LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup> &#x02192; BCR<sup>&#x02212;/&#x02212;</sup> chimeras revealed the presence of few PNA<sup>+</sup> cell clusters. Associated FDC networks were absent or significantly reduced in size (Fig. <xref ref-type="fig" rid="F2">2</xref>, E and F). Most of the PNA<sup>+</sup> cell clusters were localized within B cell areas (Fig. <xref ref-type="fig" rid="F2">2</xref>, E&#x02013;H). Albeit segregated from the T cell areas, the B cell areas did not represent well-defined B cell follicles. Spleens of LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> + B6 &#x02192; BCR<sup>&#x02212;/&#x02212;</sup> control mice showed numerous PNA<sup>+</sup> cell clusters in association with large FDC networks, most of them correctly localized within B cell follicles (Fig. <xref ref-type="fig" rid="F2">2</xref>, A&#x02013;D). With regard to FDC network formation, the absence of TNF production by B cells in TNF<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup> &#x02192; BCR<sup>&#x02212;/&#x02212;</sup> chimeras resulted in a phenotype similar to the one found in LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup> &#x02192; BCR<sup>&#x02212;/&#x02212;</sup> chimeras: few PNA<sup>+</sup> cell clusters contained considerably underdeveloped FDC networks, and most clusters lacked immunohistochemically detectable networks altogether (Fig. <xref ref-type="fig" rid="F2">2</xref>, M and N). However, in these mice, approximately two thirds of the PNA<sup>+</sup> cell clusters were located around central arterioles in T cell areas (Fig. <xref ref-type="fig" rid="F2">2</xref>, O and P) and only one third was found in B cell areas (not shown). B cells segregated from T cells and some B cell follicles were observed (not shown). In TNF<sup>&#x02212;/&#x02212;</sup> + B6 &#x02192; BCR<sup>&#x02212;/&#x02212;</sup> control chimeras, most PNA<sup>+</sup> cell clusters associated with FDC networks were readily detectable in distinct B cell follicles (Fig. <xref ref-type="fig" rid="F2">2</xref>, I&#x02013;L). All results regarding splenic FDC network formation in compound BM chimeras were confirmed by double labeling with PNA and FDC-M2 mAbs (data not shown). Taken together, the results demonstrate that expression of both LT&#x003b2; and TNF by B cells is required for the development of mature splenic FDC networks, but not for the formation of PNA<sup>+</sup> cell clusters. </p></sec><sec disp-level="4"><title>Specific Primary IgG Responses.</title><p>To investigate whether the observed abnormal GC reactions correlated with impaired specific IgG responses, NP-specific IgG titers were quantified in the sera of animals 10 d after immunization. Densely or sparsely haptenated BSA (NP<sub>12</sub>-BSA or NP<sub>5</sub>-BSA) was used for coating of ELISA plates, allowing detection of both low and high affinity NP-specific IgG. B6 &#x02192; B6 and LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> &#x02192; B6 chimeras responded to immunization with a comparable production of specific IgG, whereas B6 &#x02192; LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> animals did not mount a significant primary IgG response (Fig. <xref ref-type="fig" rid="F3">3</xref>, A and B). Moreover, significant defects were not observed in B6 &#x02192; LT&#x003b2;<sup>&#x02212;/&#x02212;</sup>, LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> &#x02192; B6, or LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> &#x02192; LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> chimeras (data not shown). In B6 &#x02192; LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> chimeras, the impaired primary IgG response correlated with multiple defects in the organization of peripheral lymphoid tissues such as lack of lymph nodes and Peyer's patches, disruption of T&#x02013;B cell segregation, and aberrant PNA<sup>+</sup> cell clusters without FDC networks in the spleen (macroscopic examination, and Fig. <xref ref-type="fig" rid="F1">1</xref>, E&#x02013;H). In contrast, LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup> &#x02192; BCR<sup>&#x02212;/&#x02212;</sup> and TNF<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup> &#x02192; BCR<sup>&#x02212;/&#x02212;</sup> mice contained lymph nodes, PNA<sup>+</sup> cell clusters, and distinct T and B cell areas, yet differed from their control groups regarding splenic FDC network formation (Fig. <xref ref-type="fig" rid="F2">2</xref>). Here, differences in NP-specific IgG titers between experimental and control groups were not statistically significant (Fig. <xref ref-type="fig" rid="F3">3</xref>, C and D), implying that a lack or strong reduction of splenic FDC networks does not necessarily lead to impaired specific primary IgG responses. </p></sec></sec><sec id="Discussion"><title>Discussion</title><p>Mice deficient for the TNFRp55 or the LT&#x003b2;R lack FDC networks and correctly localized PNA<sup>+</sup> cell clusters, demonstrating the requirement of signals from these receptors for GC formation (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>). Development of PNA<sup>+</sup> cell clusters and FDC networks in TNFRp55<sup>&#x02212;/&#x02212;</sup> mice is not rescued by transplantation of wild-type BM (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>), whereas TNFRp55<sup>&#x02212;/&#x02212;</sup> BM is as efficient as wild-type BM in reconstituting these structures in LT&#x003b1;<sup>&#x02212;/&#x02212;</sup> mice (<xref rid="B26" ref-type="bibr">26</xref>). These data indicate that for establishment of GCs, TNFRp55 is required on radioresistant stromal cells and not on radiosensitive BM-derived cells (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>). In the present study, LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> &#x02192; LT&#x003b2;<sup>&#x02212;/&#x02212;</sup>, LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> &#x02192; B6, and B6 &#x02192; LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> BM chimeric mice were used for the analysis of GC development, and evidence is provided that for formation of FDC networks expression of LT&#x003b2;R, like TNFRp55, is required on radioresistant cells, but not on BM-derived radiosensitive cells. Since FDCs are known to withstand high doses of irradiation (<xref rid="B37" ref-type="bibr">37</xref>), it is likely that putative FDC precursors are radioresistant cells that depend on signals from the TNFRp55 (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>) and the LT&#x003b2;R (this study) for differentiation to mature FDCs (Fig. <xref ref-type="fig" rid="F4">4</xref>). Alternatively, it is conceivable that radioresistant stromal cells different from FDC precursors exist that provide molecules needed for FDC maturation and depend on signals from the TNFRp55 and/or the LT&#x003b2;R in order to fulfill this function. </p><p>Comparable to LT&#x003b2;R<sup>&#x02212;/&#x02212;</sup> mice, mice with a disrupted LT&#x003b1; gene are devoid of marginal zones, proper T&#x02013;B cell segregation, correctly localized PNA<sup>+</sup> cell clusters, and FDC networks (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). Recently, experiments by Fu et al. (<xref rid="B28" ref-type="bibr">28</xref>) and Gonzalez et al. (<xref rid="B29" ref-type="bibr">29</xref>) led to the identification of the cellular source of LT&#x003b1; needed for the establishment of FDC networks and correctly localized PNA<sup>+</sup> cell clusters in the spleen. The first group used BM from LT&#x003b1;<sup>&#x02212;/&#x02212;</sup> mice mixed together with BM from TCR<sup>&#x02212;/&#x02212;</sup> or BCR<sup>&#x02212;/&#x02212;</sup> mice to reconstitute LT&#x003b1;<sup>&#x02212;/&#x02212;</sup> mice. In chimeric mice, all T or B lymphocytes were deficient in LT&#x003b1;, whereas the other cells of hematopoietic origin consisted of a mixture of LT&#x003b1;<sup>&#x02212;/&#x02212;</sup> and LT&#x003b1;<sup>+/+</sup> genotypes. The formation of PNA<sup>+</sup> cell clusters and FDC networks was precluded only in BM chimeras in which B cells were deficient for LT&#x003b1;, indicating that LT&#x003b1;-producing B cells are essential for the establishment of GCs (<xref rid="B28" ref-type="bibr">28</xref>). Gonzalez et al. (<xref rid="B29" ref-type="bibr">29</xref>) adoptively transferred purified lymphocytes into SCID mice and also showed the dependence of the FDC network on LT&#x003b1;-producing B lymphocytes. Since LT&#x003b1; together with LT&#x003b2; can form ligands specific for LT&#x003b2;R (<xref rid="B16" ref-type="bibr">16</xref>&#x02013;<xref rid="B18" ref-type="bibr">18</xref>), it was suggested that LT&#x003b1;<sub>1</sub>&#x003b2;<sub>2</sub> heterotrimers on B cells are required for FDC development. In line with this hypothesis, wild-type B cells transferred into SCID mice that were simultaneously treated with LT&#x003b2;R&#x02013;Fc fusion protein did not induce FDC networks (<xref rid="B29" ref-type="bibr">29</xref>). In our study, a mixture of BM cells from BCR<sup>&#x02212;/&#x02212;</sup> and LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> mice were transferred into irradiated BCR<sup>&#x02212;/&#x02212;</sup> recipients. In the absence of LT&#x003b2;-producing B cells, but not of LT&#x003b2;-producing T cells (Endres, R., M.B. Alimzhanov, and K. Pfeffer, unpublished results), FDC networks were strongly reduced or absent. However, PNA<sup>+</sup> cell clusters in B cell areas were observed. These results are in contrast to the findings of Fu and colleagues, who did not detect any correctly localized PNA<sup>+</sup> cell clusters and FDC-specific labeling in BCR<sup>&#x02212;/&#x02212;</sup> + LT&#x003b1;<sup>&#x02212;/&#x02212;</sup> &#x02192; LT&#x003b1;<sup>&#x02212;/&#x02212;</sup> compound BM chimeras (<xref rid="B28" ref-type="bibr">28</xref>). This discrepancy may be explained by different experimental conditions, i.e., Fu et al. reconstituted LT&#x003b1;<sup>&#x02212;/&#x02212;</sup> mice, which show a severely disorganized splenic architecture (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B38" ref-type="bibr">38</xref>), whereas here B cell&#x02013;deficient mice are reconstituted, which apart from missing B cells and FDC networks appear to have a conserved splenic architecture (Endres, R., M.B. Alimzhanov, and K. Pfeffer, unpublished results). Alternatively, it is conceivable that LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> B cells still produce LT&#x003b1; homotrimers which engage the TNFRp55 and thereby induce GC formation, although much less efficiently than wild-type B cells. However, since signaling via the LT&#x003b2;R appears indispensable for FDC development (this study, and reference <xref rid="B21" ref-type="bibr">21</xref>), in order to explain the appearance of few underdeveloped FDC clusters in LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup> &#x02192; BCR<sup>&#x02212;/&#x02212;</sup> chimeras and in LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> mice (this study, and references <xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B24" ref-type="bibr">24</xref>), one has to assume that ligands other than LT&#x003b1;<sub>1</sub>&#x003b2;<sub>2</sub> can engage the LT&#x003b2;R on radioresistant cells at least to some extent. A recently identified member of the TNF ligand family, LIGHT, may serve this function, since it was shown to bind to the LT&#x003b2;R (<xref rid="B40" ref-type="bibr">40</xref>).</p><p>Besides LT&#x003b1;<sub>3</sub> homotrimers, soluble and membrane-bound forms of TNF<sub>3</sub> signal via the TNFRp55. TNF<sup>&#x02212;/&#x02212;</sup> and TNFRp55<sup>&#x02212;/&#x02212;</sup> mice have comparable phenotypes in that they lack B cell follicles, FDC networks, and correctly localized PNA<sup>+</sup> cell clusters (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>). Since TNF is known to be produced by many cell types (<xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>), we asked whether B cell&#x02013;derived TNF is required for the induction of splenic FDC networks by generating compound TNF<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup> &#x02192; BCR<sup>&#x02212;/&#x02212;</sup> BM chimeras. Surprisingly, these chimeras did not contain mature splenic FDC networks, showing a phenotype similar to the one observed in chimeras devoid of LT&#x003b2;-producing B cells. Thus, TNF is yet another mediator in B cell&#x02013;pre-FDC interactions which lead to FDC network development. In contrast to TNF<sup>&#x02212;/&#x02212;</sup> mice (<xref rid="B19" ref-type="bibr">19</xref>), TNF<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup> &#x02192; BCR<sup>&#x02212;/&#x02212;</sup> chimeras have few underdeveloped FDC networks associated with PNA<sup>+</sup> cell clusters. This indicates that, in the absence of B cell&#x02013; derived TNF, TNF from cells other than B cells can provide signals for FDC network development albeit to a limited extent. It is noteworthy that Alexopoulou et al. observed a reduced production of TNF in LT&#x003b1;<sup>&#x02212;/&#x02212;</sup> mice after LPS treatment (<xref rid="B24" ref-type="bibr">24</xref>). The authors suggested that in the LT&#x003b1;<sup>&#x02212;/&#x02212;</sup> mouse strain (<xref rid="B38" ref-type="bibr">38</xref>), TNF gene expression is altered by the neo<sup>r</sup> cassette used to inactivate the LT&#x003b1; gene (<xref rid="B24" ref-type="bibr">24</xref>). The mutation introduced in the LT&#x003b2; gene (<xref rid="B22" ref-type="bibr">22</xref>) presumably does not interfere with the expression of the neighboring TNF and LT&#x003b1; genes. Therefore, differences in GC formation between chimeras devoid of LT&#x003b1;-producing B cells versus LT&#x003b2;-producing B cells could result from different amounts of TNF produced by LT&#x003b1;<sup>&#x02212;/&#x02212;</sup> and LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> B cells, respectively. LT&#x003b1;<sup>&#x02212;/&#x02212;</sup> B cells, but not LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> B cells, might fail to provide local TNF concentrations high enough to allow formation of few underdeveloped GCs.</p><p>One simple model of splenic FDC network maturation, which accommodates data from several groups (25, 26, 28, 29, and this study), is depicted in Fig. <xref ref-type="fig" rid="F4">4</xref>. Radioresistant stromal cells have to receive at least two different signals, one via the LT&#x003b2;R (this study) and the other via the TNFRp55 (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>), in order to give rise to a local FDC network. Most likely, these radioresistant cells represent hitherto unidentified FDC precursors, either residing at the site of B cell accumulation or attracted to this location by the B cells. Alternatively, the radioresistant cells are not FDC precursors, but serve as inducible sources of unknown factors required for differentiation of FDC precursors to mature local FDC networks. The cytokines required for FDC network development, TNF<sub>3</sub>, LT&#x003b1;<sub>3</sub> and LT&#x003b1;<sub>1</sub>&#x003b2;<sub>2</sub>, are provided by B lymphocytes (28, 29, and this study). To date, the temporal and spatial interrelations of TNFRp55 and LT&#x003b2;R transduced signals remain unclear. It is possible that these two signals act during distinct stages of FDC differentiation.</p></sec></body><back><ack><p>This study was supported by the Deutsche Forschungsgemeinschaft (grant Pf&#x02009;259/2-4) and the Sonderforschungsbereich 391 and 243, Klinische Forschergruppe Postoperative Immunparalyse und Sepsis (grant Si208/5-1). M.B. Alimzhanov was supported by a fellowship from the European Molecular Biology Organization. S.A. Nedospasov is an international research scholar of the Howard Hughes Medical Institute.</p></ack><fn-group><fn><p>The continuous and generous support of H. Wagner is greatly appreciated. The authors thank E. Schaller, U. Huffstadt, S. Weiss, and K. Mink for expert technical assistance. The authors are also grateful to H.R. Rodewald and G. Kollias for providing Ly5.1<sup>+</sup> C57BL/6 and TNF<sup>&#x02212;/&#x02212;</sup> mice, respectively, and thank H. Neubauer, T. Novobrantseva, S. Scheu, and H. H&#x000e4;cker for critical reading of the manuscript and for scientific advice. </p></fn><fn><p>R. Endres and M.B. Alimzhanov contributed equally to this work.</p></fn></fn-group><glossary><title>Abbreviations used in this paper</title><def-list><def-item><term>AP</term><def><p>alkaline phosphatase</p></def></def-item><def-item><term>FDC</term><def><p>follicular dendritic cell</p></def></def-item><def-item><term>GC</term><def><p>germinal center</p></def></def-item><def-item><term>LT</term><def><p>lymphotoxin</p></def></def-item><def-item><term>BCR</term><def><p>B cell receptor</p></def></def-item><def-item><term>PNA</term><def><p>peanut agglutinin</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></name><name><surname>Bonnefoy</surname><given-names>JY</given-names></name><name><surname>Chvatchko</surname><given-names>Y</given-names></name></person-group>
<article-title>The physiology of murine germinal center reactions</article-title>
<source>Immunol Rev</source>
<year>1997</year>
<volume>156</volume>
<fpage>127</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="pmid">9176704</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kelsoe</surname><given-names>G</given-names></name><name><surname>Zheng</surname><given-names>B</given-names></name></person-group>
<article-title>Sites of B-cell activation in vivo</article-title>
<source>Curr Opin Immunol</source>
<year>1993</year>
<volume>5</volume>
<fpage>418</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="pmid">8347301</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>MacLennan</surname><given-names>IC</given-names></name></person-group>
<article-title>Germinal centers</article-title>
<source>Annu Rev Immunol</source>
<year>1994</year>
<volume>12</volume>
<fpage>117</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="pmid">8011279</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tew</surname><given-names>JG</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>D</given-names></name><name><surname>Helm</surname><given-names>S</given-names></name><name><surname>Burton</surname><given-names>GF</given-names></name><name><surname>Szakal</surname><given-names>AK</given-names></name></person-group>
<article-title>Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells</article-title>
<source>Immunol Rev</source>
<year>1997</year>
<volume>156</volume>
<fpage>39</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="pmid">9176698</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>YJ</given-names></name><name><surname>Arpin</surname><given-names>C</given-names></name></person-group>
<article-title>Germinal center development</article-title>
<source>Immunol Rev</source>
<year>1997</year>
<volume>156</volume>
<fpage>111</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="pmid">9280752</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ware</surname><given-names>CF</given-names></name><name><surname>VanArsdale</surname><given-names>TL</given-names></name><name><surname>Crowe</surname><given-names>PD</given-names></name><name><surname>Browning</surname><given-names>JL</given-names></name></person-group>
<article-title>The ligands and receptors of the lymphotoxin system</article-title>
<source>Curr Top Microbiol Immunol</source>
<year>1995</year>
<volume>198</volume>
<fpage>175</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="pmid">7774281</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ruddle</surname><given-names>NH</given-names></name></person-group>
<article-title>Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta)</article-title>
<source>Curr Opin Immunol</source>
<year>1992</year>
<volume>4</volume>
<fpage>327</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="pmid">1329840</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tartaglia</surname><given-names>LA</given-names></name><name><surname>Goeddel</surname><given-names>DV</given-names></name></person-group>
<article-title>Two TNF receptors</article-title>
<source>Immunol Today</source>
<year>1992</year>
<volume>13</volume>
<fpage>151</fpage>
<lpage>153</lpage>
<pub-id pub-id-type="pmid">1322675</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Banner</surname><given-names>DW</given-names></name><name><surname>D'Arcy</surname><given-names>A</given-names></name><name><surname>Janes</surname><given-names>W</given-names></name><name><surname>Gentz</surname><given-names>R</given-names></name><name><surname>Schoenfeld</surname><given-names>HJ</given-names></name><name><surname>Broger</surname><given-names>C</given-names></name><name><surname>Loetscher</surname><given-names>H</given-names></name><name><surname>Lesslauer</surname><given-names>W</given-names></name></person-group>
<article-title>Crystal structure of the soluble human 55 kd TNF receptor- human TNF beta complex: implications for TNF receptor activation</article-title>
<source>Cell</source>
<year>1993</year>
<volume>73</volume>
<fpage>431</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="pmid">8387891</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kriegler</surname><given-names>M</given-names></name><name><surname>Perez</surname><given-names>C</given-names></name><name><surname>DeFay</surname><given-names>K</given-names></name><name><surname>Albert</surname><given-names>I</given-names></name><name><surname>Lu</surname><given-names>SD</given-names></name></person-group>
<article-title>A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF</article-title>
<source>Cell</source>
<year>1988</year>
<volume>53</volume>
<fpage>45</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">3349526</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O'Garra</surname><given-names>A</given-names></name><name><surname>Stapleton</surname><given-names>G</given-names></name><name><surname>Dhar</surname><given-names>V</given-names></name><name><surname>Pearce</surname><given-names>M</given-names></name><name><surname>Schumacher</surname><given-names>J</given-names></name><name><surname>Rugo</surname><given-names>H</given-names></name><name><surname>Barbis</surname><given-names>D</given-names></name><name><surname>Stall</surname><given-names>A</given-names></name><name><surname>Cupp</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>K</given-names></name></person-group>
<article-title>Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10</article-title>
<source>Int Immunol</source>
<year>1990</year>
<volume>2</volume>
<fpage>821</fpage>
<lpage>832</lpage>
<pub-id pub-id-type="pmid">1703785</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vassalli</surname><given-names>P</given-names></name></person-group>
<article-title>The pathophysiology of tumor necrosis factors</article-title>
<source>Annu Rev Immunol</source>
<year>1992</year>
<volume>10</volume>
<fpage>411</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="pmid">1590993</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pistoia</surname><given-names>V</given-names></name><name><surname>Corcione</surname><given-names>A</given-names></name></person-group>
<article-title>Relationships between B cell cytokine production in secondary lymphoid follicles and apoptosis of germinal center B lymphocytes</article-title>
<source>Stem Cells (Dayton)</source>
<year>1995</year>
<volume>13</volume>
<fpage>487</fpage>
<lpage>500</lpage>
<pub-id pub-id-type="pmid">8528098</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Browning</surname><given-names>JL</given-names></name><name><surname>Dougas</surname><given-names>I</given-names></name><name><surname>Ngam-ek</surname><given-names>A</given-names></name><name><surname>Bourdon</surname><given-names>PR</given-names></name><name><surname>Ehrenfels</surname><given-names>BN</given-names></name><name><surname>Miatkowski</surname><given-names>K</given-names></name><name><surname>Zafari</surname><given-names>M</given-names></name><name><surname>Yampaglia</surname><given-names>AM</given-names></name><name><surname>Lawton</surname><given-names>P</given-names></name><name><surname>Meier</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors</article-title>
<source>J Immunol</source>
<year>1995</year>
<volume>154</volume>
<fpage>33</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">7995952</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Browning</surname><given-names>JL</given-names></name><name><surname>Ngam-ek</surname><given-names>A</given-names></name><name><surname>Lawton</surname><given-names>P</given-names></name><name><surname>DeMarinis</surname><given-names>J</given-names></name><name><surname>Tizard</surname><given-names>R</given-names></name><name><surname>Chow</surname><given-names>EP</given-names></name><name><surname>Hession</surname><given-names>C</given-names></name><name><surname>O'Brine-Greco</surname><given-names>B</given-names></name><name><surname>Foley</surname><given-names>SF</given-names></name><name><surname>Ware</surname><given-names>CF</given-names></name></person-group>
<article-title>Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface</article-title>
<source>Cell</source>
<year>1993</year>
<volume>72</volume>
<fpage>847</fpage>
<lpage>856</lpage>
<pub-id pub-id-type="pmid">7916655</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Browning</surname><given-names>JL</given-names></name><name><surname>Sizing</surname><given-names>ID</given-names></name><name><surname>Lawton</surname><given-names>P</given-names></name><name><surname>Bourdon</surname><given-names>PR</given-names></name><name><surname>Rennert</surname><given-names>PD</given-names></name><name><surname>Majeau</surname><given-names>GR</given-names></name><name><surname>Ambrose</surname><given-names>CM</given-names></name><name><surname>Hession</surname><given-names>C</given-names></name><name><surname>Miatkowski</surname><given-names>K</given-names></name><name><surname>Griffiths</surname><given-names>DA</given-names></name><etal/></person-group>
<article-title>Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes</article-title>
<source>J Immunol</source>
<year>1997</year>
<volume>159</volume>
<fpage>3288</fpage>
<lpage>3298</lpage>
<pub-id pub-id-type="pmid">9317127</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Crowe</surname><given-names>PD</given-names></name><name><surname>VanArsdale</surname><given-names>TL</given-names></name><name><surname>Walter</surname><given-names>BN</given-names></name><name><surname>Ware</surname><given-names>CF</given-names></name><name><surname>Hession</surname><given-names>C</given-names></name><name><surname>Ehrenfels</surname><given-names>B</given-names></name><name><surname>Browning</surname><given-names>JL</given-names></name><name><surname>Din</surname><given-names>WS</given-names></name><name><surname>Goodwin</surname><given-names>RG</given-names></name><name><surname>Smith</surname><given-names>CA</given-names></name></person-group>
<article-title>A lymphotoxin-beta-specific receptor</article-title>
<source>Science</source>
<year>1994</year>
<volume>264</volume>
<fpage>707</fpage>
<lpage>710</lpage>
<pub-id pub-id-type="pmid">8171323</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Force</surname><given-names>WR</given-names></name><name><surname>Walter</surname><given-names>BN</given-names></name><name><surname>Hession</surname><given-names>C</given-names></name><name><surname>Tizard</surname><given-names>R</given-names></name><name><surname>Kozak</surname><given-names>CA</given-names></name><name><surname>Browning</surname><given-names>JL</given-names></name><name><surname>Ware</surname><given-names>CF</given-names></name></person-group>
<article-title>Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression</article-title>
<source>J Immunol</source>
<year>1995</year>
<volume>155</volume>
<fpage>5280</fpage>
<lpage>5288</lpage>
<pub-id pub-id-type="pmid">7594541</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pasparakis</surname><given-names>M</given-names></name><name><surname>Alexopoulou</surname><given-names>L</given-names></name><name><surname>Episkopou</surname><given-names>V</given-names></name><name><surname>Kollias</surname><given-names>G</given-names></name></person-group>
<article-title>Immune and inflammatory responses in TNF-&#x003b1;&#x02013;deficient mice: a critical requirement for TNF-&#x003b1; in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response</article-title>
<source>J Exp Med</source>
<year>1996</year>
<volume>184</volume>
<fpage>1397</fpage>
<lpage>1411</lpage>
<pub-id pub-id-type="pmid">8879212</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Mariathasan</surname><given-names>S</given-names></name><name><surname>Nahm</surname><given-names>MH</given-names></name><name><surname>Baranyay</surname><given-names>F</given-names></name><name><surname>Peschon</surname><given-names>JJ</given-names></name><name><surname>Chaplin</surname><given-names>DD</given-names></name></person-group>
<article-title>Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers</article-title>
<source>Science</source>
<year>1996</year>
<volume>271</volume>
<fpage>1289</fpage>
<lpage>1291</lpage>
<pub-id pub-id-type="pmid">8638112</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>F&#x000fc;tterer</surname><given-names>A</given-names></name><name><surname>Mink</surname><given-names>K</given-names></name><name><surname>Luz</surname><given-names>A</given-names></name><name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name></person-group>
<article-title>The lymphotoxin &#x003b2; receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues</article-title>
<source>Immunity</source>
<year>1998</year>
<volume>9</volume>
<fpage>59</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">9697836</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alimzhanov</surname><given-names>MB</given-names></name><name><surname>Kuprash</surname><given-names>DV</given-names></name><name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></name><name><surname>Luz</surname><given-names>A</given-names></name><name><surname>Turetskaya</surname><given-names>RL</given-names></name><name><surname>Tarakhovsky</surname><given-names>A</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name><name><surname>Nedospasov</surname><given-names>SA</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name></person-group>
<article-title>Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>1997</year>
<volume>94</volume>
<fpage>9302</fpage>
<lpage>9307</lpage>
<pub-id pub-id-type="pmid">9256477</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koni</surname><given-names>PA</given-names></name><name><surname>Sacca</surname><given-names>R</given-names></name><name><surname>Lawton</surname><given-names>P</given-names></name><name><surname>Browning</surname><given-names>JL</given-names></name><name><surname>Ruddle</surname><given-names>NH</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group>
<article-title>Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice</article-title>
<source>Immunity</source>
<year>1997</year>
<volume>6</volume>
<fpage>491</fpage>
<lpage>500</lpage>
<pub-id pub-id-type="pmid">9133428</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alexopoulou</surname><given-names>L</given-names></name><name><surname>Pasparakis</surname><given-names>M</given-names></name><name><surname>Kollias</surname><given-names>G</given-names></name></person-group>
<article-title>Complementation of lymphotoxin-&#x003b1; knockout mice with tumor necrosis factor&#x02013;expressing transgenes rectifies defective splenic structure and function</article-title>
<source>J Exp Med</source>
<year>1998</year>
<volume>188</volume>
<fpage>745</fpage>
<lpage>754</lpage>
<pub-id pub-id-type="pmid">9705956</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tkachuk</surname><given-names>M</given-names></name><name><surname>Bolliger</surname><given-names>S</given-names></name><name><surname>Ryffel</surname><given-names>B</given-names></name><name><surname>Pluschke</surname><given-names>G</given-names></name><name><surname>Banks</surname><given-names>TA</given-names></name><name><surname>Herren</surname><given-names>S</given-names></name><name><surname>Gisler</surname><given-names>RH</given-names></name><name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></name></person-group>
<article-title>Crucial role of tumor necrosis factor receptor 1 expression on nonhematopoietic cells for B cell localization within the splenic white pulp</article-title>
<source>J Exp Med</source>
<year>1998</year>
<volume>187</volume>
<fpage>469</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="pmid">9463397</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Fu</surname><given-names>YX</given-names></name><name><surname>Molina</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>DA</given-names></name><name><surname>Nahm</surname><given-names>MH</given-names></name><name><surname>Chaplin</surname><given-names>DD</given-names></name></person-group>
<article-title>Distinct roles of lymphotoxin &#x003b1; and the type I tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non-bone marrow&#x02013;derived cells</article-title>
<source>J Exp Med</source>
<year>1997</year>
<volume>186</volume>
<fpage>1997</fpage>
<lpage>2004</lpage>
<pub-id pub-id-type="pmid">9396768</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Fu</surname><given-names>YX</given-names></name><name><surname>Molina</surname><given-names>H</given-names></name><name><surname>Chaplin</surname><given-names>DD</given-names></name></person-group>
<article-title>Lymphotoxin-alpha-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers</article-title>
<source>Immunol Rev</source>
<year>1997</year>
<volume>156</volume>
<fpage>137</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="pmid">9176705</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fu</surname><given-names>YX</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chaplin</surname><given-names>DD</given-names></name></person-group>
<article-title>B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin &#x003b1;&#x02013;dependent fashion</article-title>
<source>J Exp Med</source>
<year>1998</year>
<volume>187</volume>
<fpage>1009</fpage>
<lpage>1018</lpage>
<pub-id pub-id-type="pmid">9529317</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>M</given-names></name><name><surname>Mackay</surname><given-names>F</given-names></name><name><surname>Browning</surname><given-names>JL</given-names></name><name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></name><name><surname>Noelle</surname><given-names>RJ</given-names></name></person-group>
<article-title>The sequential role of lymphotoxin and B cells in the development of splenic follicles</article-title>
<source>J Exp Med</source>
<year>1998</year>
<volume>187</volume>
<fpage>997</fpage>
<lpage>1007</lpage>
<pub-id pub-id-type="pmid">9529316</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>D</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group>
<article-title>Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion</article-title>
<source>Nature</source>
<year>1992</year>
<volume>356</volume>
<fpage>154</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="pmid">1545868</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mombaerts</surname><given-names>P</given-names></name><name><surname>Mizoguchi</surname><given-names>E</given-names></name><name><surname>Grusby</surname><given-names>MJ</given-names></name><name><surname>Glimcher</surname><given-names>LH</given-names></name><name><surname>Bhan</surname><given-names>AK</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name></person-group>
<article-title>Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice</article-title>
<source>Cell</source>
<year>1993</year>
<volume>75</volume>
<fpage>274</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="pmid">8104709</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Endres</surname><given-names>R</given-names></name><name><surname>Luz</surname><given-names>A</given-names></name><name><surname>Schulze</surname><given-names>H</given-names></name><name><surname>Neubauer</surname><given-names>H</given-names></name><name><surname>F&#x000fc;tterer</surname><given-names>A</given-names></name><name><surname>Holland</surname><given-names>SM</given-names></name><name><surname>Wagner</surname><given-names>H</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name></person-group>
<article-title>Listeriosis in p47<sup>phox&#x02212;/&#x02212;</sup> and TRp55<sup>&#x02212;/&#x02212;</sup>mice: protection despite absence of ROI and susceptibility despite presence of RNI</article-title>
<source>Immunity</source>
<year>1997</year>
<volume>7</volume>
<fpage>419</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="pmid">9324362</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cumano</surname><given-names>A</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group>
<article-title>Structure of primary anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies in normal and idiotypically suppressed C57BL/6 mice</article-title>
<source>Eur J Immunol</source>
<year>1985</year>
<volume>15</volume>
<fpage>512</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="pmid">3873342</pub-id></element-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="other">Kinoshita, T., T. Fujita, and R. Tsunoda. 1991. Expression of complement receptors CR1 and CR2 on murine follicular dendritic cells and B lymphocytes. <italic>In</italic> Dendritic Cells in Lymphoid Tissues. Y. Imai, J.G. Tew, and E.C.M. Hoefsmit, editors. Elsevier Science B.V., Amsterdam. p. 271.</mixed-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ryffel</surname><given-names>B</given-names></name><name><surname>Di Padova</surname><given-names>F</given-names></name><name><surname>Schreier</surname><given-names>MH</given-names></name><name><surname>Le Hir</surname><given-names>M</given-names></name><name><surname>Eugster</surname><given-names>HP</given-names></name><name><surname>Quesniaux</surname><given-names>VF</given-names></name></person-group>
<article-title>Lack of type 2 T cell- independent B cell responses and defect in isotype switching in TNF-lymphotoxin alpha-deficient mice</article-title>
<source>J Immunol</source>
<year>1997</year>
<volume>158</volume>
<fpage>2126</fpage>
<lpage>2133</lpage>
<pub-id pub-id-type="pmid">9036957</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ware</surname><given-names>CF</given-names></name><name><surname>Crowe</surname><given-names>PD</given-names></name><name><surname>Grayson</surname><given-names>MH</given-names></name><name><surname>Androlewicz</surname><given-names>MJ</given-names></name><name><surname>Browning</surname><given-names>JL</given-names></name></person-group>
<article-title>Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells</article-title>
<source>J Immunol</source>
<year>1992</year>
<volume>149</volume>
<fpage>3881</fpage>
<lpage>3888</lpage>
<pub-id pub-id-type="pmid">1281193</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Humphrey</surname><given-names>JH</given-names></name><name><surname>Grennan</surname><given-names>D</given-names></name><name><surname>Sundaram</surname><given-names>V</given-names></name></person-group>
<article-title>The origin of follicular dendritic cells in the mouse and the mechanism of trapping of immune complexes on them</article-title>
<source>Eur J Immunol</source>
<year>1984</year>
<volume>14</volume>
<fpage>859</fpage>
<lpage>864</lpage>
<pub-id pub-id-type="pmid">6479210</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Togni</surname><given-names>P</given-names></name><name><surname>Goellner</surname><given-names>J</given-names></name><name><surname>Ruddle</surname><given-names>NH</given-names></name><name><surname>Streeter</surname><given-names>PR</given-names></name><name><surname>Fick</surname><given-names>A</given-names></name><name><surname>Mariathasan</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>SC</given-names></name><name><surname>Carlson</surname><given-names>R</given-names></name><name><surname>Shornick</surname><given-names>LP</given-names></name><name><surname>Strauss-Schoenberger</surname><given-names>J</given-names></name><name><surname>Chaplin</surname><given-names>DD</given-names></name></person-group>
<article-title>Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin</article-title>
<source>Science</source>
<year>1994</year>
<volume>264</volume>
<fpage>703</fpage>
<lpage>707</lpage>
<pub-id pub-id-type="pmid">8171322</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Banks</surname><given-names>TA</given-names></name><name><surname>Rouse</surname><given-names>BT</given-names></name><name><surname>Kerley</surname><given-names>MK</given-names></name><name><surname>Blair</surname><given-names>PJ</given-names></name><name><surname>Godfrey</surname><given-names>VL</given-names></name><name><surname>Kuklin</surname><given-names>NA</given-names></name><name><surname>Bouley</surname><given-names>DM</given-names></name><name><surname>Thomas</surname><given-names>J</given-names></name><name><surname>Kanangat</surname><given-names>S</given-names></name><name><surname>Mucenski</surname><given-names>ML</given-names></name></person-group>
<article-title>Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness</article-title>
<source>J Immunol</source>
<year>1995</year>
<volume>155</volume>
<fpage>1685</fpage>
<lpage>1693</lpage>
<pub-id pub-id-type="pmid">7636227</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mauri</surname><given-names>DN</given-names></name><name><surname>Ebner</surname><given-names>R</given-names></name><name><surname>Montgomery</surname><given-names>RI</given-names></name><name><surname>Kochel</surname><given-names>KD</given-names></name><name><surname>Cheung</surname><given-names>TC</given-names></name><name><surname>Yu</surname><given-names>GL</given-names></name><name><surname>Ruben</surname><given-names>S</given-names></name><name><surname>Murphy</surname><given-names>M</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name><etal/></person-group>
<article-title>LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator</article-title>
<source>Immunity</source>
<year>1998</year>
<volume>8</volume>
<fpage>21</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">9462508</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p>Splenic GC development in reciprocal BM chimeric mice. Irradiated recipients (<italic>n</italic> = 3&#x02013;5 per group) were reconstituted with BM from donors as indicated. After 8 wk, chimeras were immunized intraperitoneally with 5 &#x003bc;g NP<sub>19</sub>-CG adsorbed to alum. 10 d later, chimeras were killed and splenic cryosections were labeled with anti-CR1 (brown) and PNA (blue); anti-B220 (brown) and PNA (blue); or anti-CD4 (brown), anti-CD8 (brown), and anti-IgD (blue).</p></caption><graphic xlink:href="JEM981584.f1"/></fig><table-wrap id="TI" position="float"><label>Table I</label><caption><p>Degree of Chimerism in Compound BM Chimeras </p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Donor BM</th><th rowspan="2" colspan="1"/><th rowspan="2" colspan="1">Recipient</th><th rowspan="2" colspan="1"/><th rowspan="2" colspan="1">Mouse no.</th><th rowspan="2" colspan="1"/><th colspan="3" rowspan="1">Chimerism</th></tr><tr><th rowspan="1" colspan="1">BM</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">B cells</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td colspan="3" rowspan="1">
<italic>%</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> + B6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">BCR<sup>&#x02212;/&#x02212;</sup>
</td><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">75 (s)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">79 (f)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">70 (s)</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">79 (f)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">64 (s)</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">82 (f)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">79 (s)</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">79 (f)</td></tr><tr><td align="left" rowspan="1" colspan="1">LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">BCR<sup>&#x02212;/&#x02212;</sup>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">67 (s)</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">98 (s)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">70 (s)</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">96 (s)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">86 (s)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">ND</td></tr><tr><td align="left" rowspan="1" colspan="1">TNF<sup>&#x02212;/&#x02212;</sup> + B6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">BCR<sup>&#x02212;/&#x02212;</sup>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">54 (s)</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">67 (f)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">81 (s)</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">69 (f)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">66 (s)</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">76 (f)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1">ND</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">62 (f)</td></tr><tr><td align="left" rowspan="1" colspan="1">TNF<sup>&#x02212;/&#x02212;</sup> + BCR<sup>&#x02212;/&#x02212;</sup>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">BCR<sup>&#x02212;/&#x02212;</sup>
</td><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">64 (s)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">97 (s)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">57 (s)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">97 (s)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">61 (s)</td><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1">ND</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">68 (s)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">ND</td></tr></tbody></table><table-wrap-foot><fn><p>BM cells and peripheral B cells were purified as described in Materials and Methods. Chimerism was determined by Southern blotting (s) and/or by flow cytometric separation (f) of Ly5.1<sup>+</sup> and Ly5.2<sup>+</sup> cells and given as percentage of LT&#x003b2;<sup>&#x02212;/&#x02212;</sup> or TNF<sup>&#x02212;/&#x02212;</sup> cells. The isolated peripheral B cells were 94&#x02013;98% pure. &#x000a0;</p></fn></table-wrap-foot></table-wrap><fig id="F2" position="float"><label>Figure 2</label><caption><p>Splenic GC development in compound BM chimeric mice. Irradiated recipients (<italic>n</italic> = 4 per group) were reconstituted with a 1:1 mixture of BM cells originating from the two donors indicated. After 6&#x02013;7 wk, the mixed BM chimeras were immunized intraperitoneally with 5 &#x003bc;g NP<sub>19</sub>-CG adsorbed to alum. 10 d later, chimeras were killed and splenic cryosections were labeled with anti-CR1 (brown) and PNA (blue); anti-B220 (brown) and PNA (blue); or anti-CD4 (brown), anti-CD8 (brown), and anti-IgD (blue).</p></caption><graphic xlink:href="JEM981584.f2"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>NP-specific IgG titers in the sera of reciprocal (A and B) and mixed BM chimeras (C and D). Chimeric mice were made and immunized as described in the legends to Figs. <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref> (<italic>n</italic> = 3&#x02013;5 per group). Sera were taken before and 10 d after immunization. The amounts of anti-NP antibodies were determined as described in Materials and Methods. Note that two different batches of NP<sub>19</sub>-CG adsorbed to alum were used for immunization, precluding a direct comparison of values from A and B with those from C and D. &#x02022;, All values were below the detection limit.</p></caption><graphic xlink:href="JEM981584.f3"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Model of the molecular interactions essential for the establishment of splenic FDC networks associated with PNA<sup>+</sup> cell clusters. B cells provide the ligands LT&#x003b1; (references <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>), TNF, and LT&#x003b2; required for an effective engagement of the TNFRp55 (references <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>) and the LT&#x003b2;R on specific radioresistant cells, which most likely represent FDC precursors. In this cell population, both signaling pathways have to be functional for mature splenic FDC networks to form. Note that the present data do not elucidate whether signaling from the TNFRp55 and the LT&#x003b2;R has to occur simultaneously or consecutively in the putative FDC precursors. TNFRI, TNFRp55.</p></caption><graphic xlink:href="JEM981584.f4"/></fig></floats-group></article>
